| . |
 |
 |
Read our Best Practice case studies for healthcare professionals . . .
Embedding equality and diversity
Low profile for equality and diversity
Click here for more
Our Manor: better together
Need for staff engagement to deliver strategic vision
Click here for more
Big Staff Conversation - change agenda
Engaging with staff in hard-to-reach groups
Click here for more
Consultant recruitment, induction and development
Inadequate appointment system for consultants
Click here for more
Listening into action
The need to increase staff satisfaction in a large acute trust
Click here for more
|
 |
| | |
|
Online news - 7 August 2008
|
 To read the rest of this FREE news item click here |
Providers are monitoring of controlled drugs better
NHS and private healthcare providers have taken positive steps to improve the monitoring and management of controlled drugs following the Shipman Inquiry. But more work is necessary to ensure all concerns are picked up, investigated and, where appropriate, action is taken. This is the main finding of a Healthcare Commission report published.
A new report by the Healthcare Commission outlines the steps that have been taken to improve monitoring of controlled drugs since the Controlled Drugs (Supervision of Management and Use) Regulations came into force in England on 1 January 2007.
Read related items on:::
Legal and regulatory
Healthcare Commission
Publications
|
| |
|
